Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’

被引：0
|
作者：
M J Molina-Garrido
C Guillén-Ponce
机构：
[1] Medical Oncology Section in the Hospital Virgen de la Luz in Cuenca,
[2] Medical Oncology Service in the Hospital Ramón y Cajal in Madrid,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：224 / 225
页数：1
相关论文
共 50 条
  • [31] A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer
    Cabebe, Elwyn C.
    Fisher, George A.
    Sikic, Branimir I.
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1082 - 1087
  • [32] A phase I trial of vandetanib combined with capecitabine, oxaliplatin and bevacizumab for the first-line treatment of metastatic colorectal cancer
    Elwyn C. Cabebe
    George A. Fisher
    Branimir I. Sikic
    [J]. Investigational New Drugs, 2012, 30 : 1082 - 1087
  • [33] Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
    Franken, M. D.
    van Rooijen, E. M.
    May, A. M.
    Koffijberg, H.
    van Tinteren, H.
    Mol, L.
    ten Tije, A. J.
    Creemers, G. J.
    van der Velden, A. M. T.
    Tanis, B. C.
    Groot, C. A. Uyl-de
    Punt, C. J. A.
    Koopman, M.
    van Oijen, M. G. H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 75 : 204 - 212
  • [34] NICE guidance on bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer
    Umeweni, Nwamaka
    Nolan, Kay
    Knight, Helen
    Clark, Peter
    [J]. LANCET ONCOLOGY, 2012, 13 (10): : 977 - 978
  • [35] Efficacy of Bevacizumab-Capecitabine in Combination for the First-Line Treatment of Metastatic Breast Cancer
    Dyar, Stephen
    Moreno-Aspitia, Alvaro
    [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 239 - 246
  • [36] Impact of the addition of bevacizumab, oxaliplatin or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.
    Landre, Thierry
    Aparicio, Thomas
    Ghebriou, Djamel
    Nicolas, Patrick
    Taleb, Cherifa
    Chouahnia, Kader
    Zelek, Laurent H.
    Des Guetz, Gaetan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [37] The role of capecitabine in first-line treatment for patients with metastatic breast cancer
    Gelmon, Karen
    Chan, Arlene
    Harbeck, Nadia
    [J]. ONCOLOGIST, 2006, 11 : 42 - 51
  • [38] FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF BRAF MUTANT METASTATIC COLORECTAL CANCER PATIENTS
    Salvatore, Lisa
    Loupakis, Fotios
    Cremolini, Chiara
    Schirripa, Marta
    Masi, Gianluca
    Antoniotti, Carlotta
    Fornaro, Lorenzo
    Sensi, Elisa
    Lupi, Cristiana
    Bergamo, Francesca
    Lonardi, Sara
    Zagonel, Vittorina
    Fontanini, Gabriella
    Falcone, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 93 - 93
  • [39] Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment
    Huang, Ching-Wen
    Yeh, Yung-Sung
    Ma, Cheng-Jen
    Tsai, Hsiang-Lin
    Chen, Chao-Wen
    Huang, Ming-Yii
    Lu, Chien-Yu
    Wu, Jeng-Yih
    Wang, Jaw Yuan
    [J]. CHEMOTHERAPY, 2017, 62 (01) : 80 - 84
  • [40] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    [J]. ONCOLOGIST, 2012, 17 (04): : 513 - 524
12345